Of these patients, 452 were screened with a coronary computed tomography angiography (CCTA), which uses a powerful X-ray to make a 3D image of the heart. Researchers compared these patients with a ...

Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to ...

CCTA is a noninvasive diagnostic test that combines X-ray and other technology to produce detailed, three-dimensional images of the heart’s arteries. Leveraging artificial intelligence (AI ...

The US Food and Drug Administration (FDA) has granted clearance to Caristo Diagnostics for CaRi-Plaque, an AI-assisted ...

While CCTA scans are commonly used to capture images ... By refining his technology, he aims to not only improve heart disease diagnoses but also expand his work to other areas of medicine.

HeartLung Technologies to debut its FDA designated "Breakthrough" AI technology (AutoChamberTM) at ACC 2025, offering lifesaving AI solutions for CVD prevention. Marlon Montes HeartLung Corporation +1 ...

Bunkerhill Health, a leader in AI-enabled early disease detection, and Cleerly, a pioneer in advanced cardiovascular imaging, announced today a strategic partnership to expand access to their ...

The CaRi-Plaque technology supports non-invasive analysis of coronary anatomy and pathology from routine coronary computed ...

personalised heart attack prevention. For preliminary plaque analysis from CCTA scans, healthcare professionals can send CT data for analysis. First sent to a cloud-based platform, Caristo then de ...